Skip to main content
logo
McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
841.67
+21.38 (2.61%)
At close: Nov 4, 2025, 4:00 PM EST
845.05
+3.38 (0.40%)
After-hours: Nov 4, 2025, 7:44 PM EST

Revenue

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222016 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 2016 - 2021
US Pharmaceutical Revenue
345.96B327.72B
Log In
Log In
Log In
Upgrade
Prescription Technology Solutions Revenue
5.41B5.22B
Log In
Log In
Log In
Upgrade
Medical Surgical Solutions Revenue
11.45B11.39B
Log In
Log In
Log In
Upgrade
International Revenue
14.77B14.72B
Log In
Log In
Log In
Upgrade
Revenue (Other)
11.00M11.00M
Log In
Log In
Log In
Upgrade
Revenue (Total)
377.60B359.05B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222016 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 2016 - 2021
US Pharmaceutical Operating Profit
3.95B4.00B
Log In
Log In
Log In
Upgrade
Prescription Technology Solutions Operating Profit
925.00M875.00M
Log In
Log In
Log In
Upgrade
Medical Surgical Solutions Operating Profit
806.00M773.00M
Log In
Log In
Log In
Upgrade
International Operating Profit
-211.00M-213.00M
Log In
Log In
Log In
Upgrade
Operating Income (Other)
-1.04B-1.02B
Log In
Log In
Log In
Upgrade
Operating Income (Total)
4.43B4.42B
Log In
Log In
Log In
Upgrade

Capital Expenditures

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222016 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 2016 - 2021
US Pharmaceutical Capital Expenditures
-241.00M
Log In
Log In
Log In
Upgrade
Prescription Technology Solutions Capital Expenditures
-11.00M
Log In
Log In
Log In
Upgrade
Medical Surgical Solutions Capital Expenditures
-163.00M
Log In
Log In
Log In
Upgrade
International Capital Expenditures
-107.00M
Log In
Log In
Log In
Upgrade
Updated Aug 6, 2025. Data Source: Fiscal.ai.